It appears that women with early breast cancer who are prescribed treatment with aromatase inhibitors (AIs) are more likely to discontinue or not follow through with this therapy if insurance copayments are high. These results were presented at the 2010 …
Tag: breast cancer treatment
Estrogen Alone May Reduce Breast Cancer Risk in Certain Women
Among women at low risk of breast cancer, postmenopausal hormone therapy with estrogen alone may reduce the risk of breast cancer. These results—which warrant additional research and should not be considered conclusive—came from further review of the Women’s Health Initiative …
Xgeva Delays Bone Complications in Women with Metastatic Breast Cancer
In a study of women with bone metastases from breast cancer, Xgeva™ (denosumab) delayed bone complications for five months longer than Zometa® (zoledronic acid). These updated results from a Phase III clinical trial were presented at the 2010 San Antonio …
Effexor Preferred over Neurontin for Hot Flashes Among Breast Cancer Survivors
Women with a history of breast cancer appear to prefer the antidepressant Effexor® (venlafaxine) over the antiseizure drug Neurontin® (gabapentin) for treatment of hot flashes. These findings were recently released in the Journal of Clinical Oncology. Hot flashes can be …
Avastin Fails to Show Benefit in Early Breast Cancer
The addition of the targeted drug Avastin® (bevacizumab) to chemotherapy did not improve outcomes among women receiving preoperative chemotherapy for early stage breast cancer. The results of this Phase III clinical trial were presented at the 2010 San Antonio Breast …
Obesity Linked with Worse Survival in Hormone Receptor-Positive Breast Cancer
In women diagnosed with estrogen receptor (ER) positive HER2 negative breast cancer, obesity may contribute to poorer survival rates. These results were presented at the 2010 San Antonio Breast Cancer Symposium. Obesity is a significant public health concern that can …
Circulating Tumor Cells Linked with Recurrence of Early Breast Cancer
Among women with early breast cancer, the presence of circulating tumor cells (cancer cells in the bloodstream) increased the risk of cancer recurrence and shortened survival. These preliminary results were presented at the 2010 San Antonio Breast Cancer Symposium. Among …
Some Patients with Advanced Cancer Continue Screening
A significant proportion of patients with advanced cancers continue to undergo cancer screening, even though screening is unlikely to benefit these patients. These findings were recently reported in the Journal of the American Medical Association. Cancer screening can detect disease …
Pregnancy Doesn’t Appear to Worsen Breast Cancer Outcomes
According to the results of a study conducted at the M. D. Anderson Cancer Center, women who are diagnosed with breast cancer and treated with chemotherapy while pregnant have a better disease free survival (survival without a cancer recurrence or …
European Study Reports that Oncotype DX® Influences Breast Cancer Treatment Decisions
Consistent with what has been reported in the United States, use of the Oncotype DX® breast cancer test influenced treatment decisions for early stage breast cancer patients in Spain. These results were presented at the 35th European Society for Medical …